CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CAS Shanghai Institutes for Biological Sciences spinout Aptbio secured funding to enhance its mass spectrometry drug screening business.

The Parkinson's disease therapy developer completed a series A round featuring QB3-aligned Mission Bay Capital.

SwanBio, based on research at Harvard Medical School, has secured a $20m extension to bring its series A round to $45m so far, with commitments to increase it to $77m.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.

Paige.ai has now raised $75m to date, with the latest funding set to help refine its cancer pathology software offering.